This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer
A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer
Breast Cancer Research 2009, 11(Suppl 1):P33 doi:10.1186/bcr2316
Accesses
- Last 30 days: 17 accesses
- Last 365 days: 125 accesses
- All time: 524 accesses